Active Stocks to Watch: Morgan Stanley (NYSE:MS), New York & Company Inc. (NYSE:NWY), Halozyme Therapeutics (NASDAQ:HALO), Encana Corporation (NYSE:ECA), ManpowerGroup (NYSE:MAN)


On Monday shares of Morgan Stanley (NYSE:MS) closed at $36.31. Company’s sales growth for last 5 years was 4.80% and EPS growth for next 5 years is recorded as 15.49%. On March 19, it was reported that, Morgan Stanley (NYSE:MS) shuffled a pair of senior executives between its securities and wealth-management divisions, in a bid to broaden their experiences while forging ties between its two largest businesses. Raj Dhanda, an investment banker who co-headed Morgan Stanley’s capital markets arm, will move to the firm’s wealth management division, where brokers advise individual investors.

New York & Company Inc. (NYSE:NWY) in last trading activity advanced 10.33% to close at $2.35. Company weekly performance is 6.82% while its quarterly performance stands at -4.08%. New York & Company Inc. (NYSE:NWY) is -53.92% away from its 52 week high. On March 19, New York & Company, Inc. (NYSE:NWY) announced results for the fourth quarter and fiscal year ended January 31, 2015. Net sales were $267.4 million, as compared to $271.0 million in the prior year. Comparable store sales decreased 0.9%, following an increase of 1.2% for the same period last year.

On last trading day Halozyme Therapeutics, Inc. (NASDAQ:HALO) decreased -3.96% to close at $14.05. Its volatility for the week is 5.66% while volatility for the month is 4.43%. HALO’s sales growth for past 5 years was 40.60% and its EPS growth for past 5 years was 3.50%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) monthly performance is -8.59%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced the appointment of James S. Mazzola as vice president, Corporate Communications and Investor Relations, reporting to President and CEO Dr. Helen Torley. Mr. Mazzola will be responsible for the creation and implementation of integrated communication and branding efforts that support Halozyme’s business objectives to all key stakeholders, including investors, employees, media, corporate partners, patients, clinicians and the scientific community.

Encana Corporation (NYSE:ECA) institutional ownership stands at 67.20%. In last trading activity company’s stock closed at $11.17. Encana Corporation (NYSE:ECA) announced the closure of its previously declared over-allotment option associated with the 85,616,500 share offering. The company stated that underwriters have fully exercised the over-allotment option of buying 12,842,475 company shares, generating additional funds of about C$187.5 million.

On last trading day ManpowerGroup Inc. (NYSE:MAN) advanced 0.06% to close at $86.70. Its volatility for the week is 1.72% while volatility for the month is 2.02%. MAN’s sales growth for past 5 years was 5.30% and its EPS growth for past 5 years was 115.20%. ManpowerGroup Inc. (NYSE:MAN) monthly performance is 9.06%. ManpowerGroup Inc (NYSE:MAN) had its price target increased by RBC Capital from $80.00 to $86.00 in a research report sent to investors on Friday morning. The firm currently has a sector perform rating on the stock.


Leave a Reply

Your email address will not be published. Required fields are marked *